We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current SCPH market cap is 144.12M. The company's latest EPS is USD -1.0953 and P/E is -2.66.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 3.8M | 6.1M | 6.1M | 8.05M | 10.03M |
| Operating Income | -14.84M | -15.26M | -15.86M | -14.43M | -18.15M |
| Net Income | -15.63M | -13.81M | -14.11M | -17.09M | -35.11M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 13.59M |
| Operating Income | -32.91M | -29.93M | -25.82M | -36.16M | -55.4M |
| Net Income | -33M | -32.21M | -28.03M | -36.84M | -54.81M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 106.1M | 94.48M | 78.45M | 65.46M | 125.07M |
| Total Liabilities | 56.96M | 57.26M | 53.89M | 56.21M | 94.36M |
| Total Equity | 49.15M | 37.22M | 24.57M | 9.25M | 30.71M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 77.28M | 109.05M | 79.04M | 124.2M | 94.48M |
| Total Liabilities | 25.92M | 26.88M | 22.57M | 51.76M | 57.26M |
| Total Equity | 51.37M | 82.17M | 56.47M | 72.43M | 37.22M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -44.09M | -59.24M | -17.7M | -37.93M | -55.35M |
| Investing | -6.5M | 19.97M | 29.32M | 29.32M | 29.31M |
| Financing | 14.38M | 14.85M | 15k | 298k | 70.71M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -30.44M | -27.69M | -27.15M | -34.58M | -59.24M |
| Investing | N/A | -33.46M | 32.13M | -45.86M | 19.97M |
| Financing | 13.59M | 60.35M | -2.53M | 77.23M | 14.85M |
| Market Cap | 144.12M |
| Price to Earnings Ratio | -2.66 |
| Price to Sales Ratio | 10.71 |
| Price to Cash Ratio | 3.11 |
| Price to Book Ratio | 3.91 |
| Dividend Yield | - |
| Shares Outstanding | 50.04M |
| Average Volume (1 week) | 825.77k |
| Average Volume (1 Month) | 450.57k |
| 52 Week Change | -51.35% |
| 52 Week High | 6.20 |
| 52 Week Low | 2.8801 |
| Spread (Intraday) | 0.25 (8.14%) |
| Company Name | scPharmaceuticals Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.scpharmaceuticals.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
